Sage Therapeutics Inc.’s stock slid 4.7% Thursday, after the biotech said it’s cutting about 33% of its workforce as part of an overhaul of its business and pipeline that’s expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback